EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Plug‐and‐Play MOF Encapsulation for Targeted Intracellular Delivery of Therapeutic Proteins

Beatriz Lozano‐Torres, Jesús Cases Díaz, Mónica Giménez‐Marqués

Small · 20.11.2026

DOI: 10.1002/smll.76646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 20.11.2026. Verfasst von Beatriz Lozano‐Torres und 2 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Federación Española de Enfermedades Raras, Generalitat Valenciana, Ministerio de Ciencia, Innovación y Universidades.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein therapy holds promise for treating a wide range of diseases; however, its clinical translation is often limited by poor stability and inefficient intracellular delivery. Building on our reported in situ encapsulation strategy for biomacromolecules in MIL‐100(Fe), we present here a miniaturized and resource‐efficient approach that enables the incorporation of high‐value proteins under mild conditions. This adaptation significantly reduces material consumption while maintaining the generality of the method, allowing proteins to be encapsulated regardless of their surface properties and overcoming key limitations of conventional post‐synthetic loading strategies. As a proof of concept, the cytotoxic protease Granzyme B (GrB) is encapsulated during MOF formation to produce GrB@MIL‐100(Fe) nanoparticles. These can be further functionalized in a modular manner with Perforin (Prf), to promote endosomal escape, and Trastuzumab (Tz), to target HER2‐overexpressing breast cancer cells. The resulting system is efficiently internalized by human breast cancer UACC‐812 cells, where partial degradation of the framework under endosomal conditions enables protein release. Perforin enhances endosomal escape in up to 37% of cells under the tested conditions; however, cytosolic delivery remains limited, leading to moderate cytotoxic effects. Altogether, these results highlight the potential of this miniaturized encapsulation strategy as a simple, adaptable platform for protein delivery.

Förderung

  • Federación Española de Enfermedades Raras
  • Generalitat Valenciana
  • Ministerio de Ciencia, Innovación y Universidades

Zitieren

APA

Lozano‐Torres, B., Díaz, J. C., & Giménez‐Marqués, M. (2026). Plug‐and‐Play MOF Encapsulation for Targeted Intracellular Delivery of Therapeutic Proteins. Small. https://doi.org/10.1002/smll.76646

Vancouver

Lozano‐Torres B, Díaz JC, Giménez‐Marqués M. Plug‐and‐Play MOF Encapsulation for Targeted Intracellular Delivery of Therapeutic Proteins. Small. 2026. doi:10.1002/smll.76646

BibTeX
@article{LozanoTorres2026,
  author = {Lozano‐Torres, Beatriz and Díaz, Jesús Cases and Giménez‐Marqués, Mónica},
  title = {Plug‐and‐Play MOF Encapsulation for Targeted Intracellular Delivery of Therapeutic Proteins},
  journal = {Small},
  year = {2026},
  doi = {10.1002/smll.76646}
}
Kostenlos starten →